Published Date: 2009-11-29 20:00:03
Subject: PRO/AH/EDR> Influenza pandemic (H1N1) 2009 (117): Japan, encephalopathy
Archive Number: 20091129.4089
INFLUENZA PANDEMIC (H1N1) 2009 (117): JAPAN, ENCEPHALOPATHY
***********************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>
Date: Sat 28 Nov 2009
Source: Infectious Diseases Weekly Report Japan, 45th week,
Infectious Disease Surveillance Center, pages 16-20 [trans. Kunihiko
Iizuka, edited]
<http://idsc.nih.go.jp/idwr/kanja/idwr/idwr2009/idwr2009-45.pdf>
Influenza encephalopathy by pandemic (H1N1) 2009 virus
--------------------------------------
(1) Encephalopathy cases: week 28 to 45: 128 cases from 30 prefectures
Virus type: Pandemic (H1N1) 116 cases (88 percent), A type 15 cases,
B type 1 case
Ages: Under 15 years - 95.5 percent, median 8 years, range 1-67
(For comparison in weeks 1 to 27, there were 48 cases of encephalopathy)
(2) Total of acute influenza encephalopathy cases as a result of
pandemic (H1N1) influenza virus infection in Japan
60 reported cases as of 13 Nov 2009
Median: 8 years
Sex: male 35, female 25
25 cases had diseases before influenza infection
All 60 cases had disturbance of consciousness:
Days of beginning of onset of fever to disturbance of consciousness:
Median - 1 day
0 day - 12 cases
1 day - 36 cases
2 days - 8 cases
a single case - 3,4,7 & 8 days
Level by Japan Coma Scale (JCS):
Over 20 - 34 cases(GCS A-3)
10-19 - 9 cases(GCS A-4)
1-9 - 16 cases
unidentified -1 case
Period of disturbance of consciousness:
Unidentified - 2 cases
Over 48 hours - 19 cases
24-48 hours - 15 cases
Under 24 hours - 15 cases
Miscellaneous:
Cramps - 31 cases of 60 (52 percent)
Abnormal behaviors - 45 cases of 60 (75 percent)
Abnormal electroencephalogram - 35/47 (74 percent)
Brain CT - 23/56 (41 percent)
Brain MRI - 14/47 (30 percent)
No signals from electroencephalogram, CT and MRI - 8 cases
Treatment:
Tamiflu - 38/60 (63 percent)
Relenza - 13/60 (22 percent)
Both - 9/60 (15 percent)
Period of drug dose to disturbance of consciousness:
Median - 1 day
Before disturbance of consciousness - 12/60 (20 percent)
Same day - 38/60 (63 percent)
1 day - 10/60 (17 percent)
Brain low temp 6/60 (10 percent)
Blood plasma change 1/60 (2 percent)
Respirator 12/60 (20 percent)
None 13/60
Outcome:
Death - 3/59 (5 percent) (4.5.7 years)
After effects - 7/59 (12 percent)
Healing - 49/59 (83 percent)
Bed days in 50 cases - 2-39 days (median 9 days)
--
Communicated by:
Kunihiko Iizuka
[There was a report of cases of encephalitis and encephalopathy
following infection with the pandemic H1N1 influenza virus in the USA
earlier this year [2009]. The MMWR editorial note mentioned the
following: "Neurologic complications in children associated with
seasonal influenza have included acute cognitive and behavioral
problems, focal neurologic deficits, and death from neurologic
complications (4). Influenza-associated neurologic complications are
estimated to account for up to 5 percent of cases of acute childhood
encephalitis or encephalopathy (4) and were reported in 6 percent of
influenza-associated deaths among children during one influenza
season (2003-04) in the United States (5). The epidemiology of
influenza-associated encephalopathy has been described extensively in
Japan, where incidence has appeared to be higher than in other
countries (1). In Japan, approximately 80 percent of
influenza-associated encephalopathy cases occur in children aged less
than 5 years (1,6), and neurologic signs typically develop within 1-2
days of influenza symptom onset (1,6). Manifestations have included
seizures, altered consciousness, incoherence, irritability, and
psychotic behaviors (1,6). Outcomes reported in one case-series from
Japan ranged from complete resolution (in nearly 50 percent of
cases), to mild (20 percent) or severe neurologic sequelae (10
percent), to death (20 percent) (6). (See: Neurologic Complications
Associated with Novel Influenza A (H1N1) Virus Infection in Children
--- Dallas, Texas, May 2009. 24 Jul 2009. 58(28));773-778.
<http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5828a2.htm>).
References from the MMWR article:
1.Morishima T, Togashi T, Yokota S, et al. Encephalitis and
encephalopathy associated with an influenza epidemic in Japan. Clin
Infect Dis 2002;35:512--7.
2.Maricich SM, Neul JL, Lotze TE, et al. Neurologic complications
associated with influenza A in children during the 2003--2004
influenza season in Houston, Texas. Pediatrics 2004;114:e626--33.
3.Dawood FS, Jain S, Finelli L, et al. Emergence of a novel
swine-origin influenza A (H1N1) virus in humans. N Engl J Med
2009;360:2605--15.
4.Amin R, Ford-Jones E, Richardson SE, et al. Acute childhood
encephalitis and encephalopathy associated with influenza: a
prospective 11-year review. Pediatr Infect Dis J 2008;27:390--5.
5.Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths
among children in the United States, 2003--2004. N Engl J Med
2005;353:2559--67.
6.Wada T, Morishima T, Okumura A, et al. Differences in clinical
manifestations of influenza-associated encephalopathy by age.
Microbiol Immunol 2009;53:83--8.
7.Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus
RNA by reverse transcription-PCR and proinflammatory cytokines in
influenza-virus-associated encephalopathy. J Med Virol
1999;58:420--5. - Mod.MPP]
[Acute necrotizing encephalopathy (ANE) typically affects young,
healthy children who develop rapid-onset severe encephalopathy
triggered by viral infections. This disease is more commonly reported
in Japan but occurs worldwide, although it remains under-recognized
in Western countries. (For description of a genetic component in the
condition, see: Im Dev Med Child Neurol. 2009 Oct 7, Gika AD, Rich P,
Gupta S, Neilson DE, Clarke A. (Department of Paediatric Neurology,
St George's Hospital NHS Trust, London, UK.) - Mod.CP]
See Also
Influenza pandemic (H1N1) 2009 (116): origin 20091126.4052Influenza pandemic (H1N1) 2009 (115): USA (WV) repeat infection 20091125.4047
Influenza pandemic (H1N1) 2009 (114): USA (WV), repeat infection 20091124.4039
Influenza pandemic (H1N1) 2009 (113): Saudi Arabia, Hajj fatalities
20091122.4013
Influenza pandemic (H1N1) 2009 (112): Canada (MB), vaccine reaction
20091121.4009
Influenza pandemic (H1N1) 2009 (111): Norway, mutants 20091121.4005
Influenza pandemic (H1N1) 2009 (110): UK (Wales), Tamiflu resistance
20091120.4000
Influenza pandemic (H1N1) 2009 (100): Ukraine (DT) 20091114.3940
Influenza pandemic (H1N1) 2009 (90): Venezuela, Yanomami 20091105.3820
Influenza pandemic (H1N1) 2009 (80): Ukraine susp. RFI 20091031.3764
Influenza pandemic (H1N1) 2009 (70): Nepal 20091016.3563
Influenza pandemic (H1N1) 2009 (60): bacterial coinfection 20090930.3410
Influenza pandemic (H1N1) 2009 (50): oseltamivir-resistance 20090917.3260
Influenza pandemic (H1N1) 2009 (40): global update 20090906.3138
Influenza pandemic (H1N1) 2009 (30): assumptions 20090813.2879
Influenza pandemic (H1N1) 2009 (20): Peru, 33 percent asymptomatic
20090730.2668
Influenza pandemic (H1N1) 2009 (10): vaccine 20090720.2577
Influenza pandemic (H1N1) 2009 - Viet Nam: patient data 20090708.2450
...................................................cp/msp/mpp/msp/lm
*##########################################################*
************************************************************
ProMED-mail makes every effort to verify the reports that
are posted, but the accuracy and completeness of the
information, and of any statements or opinions based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by ProMED-mail. ISID
and its associated service providers shall not be held
responsible for errors or omissions or held liable for any
damages incurred as a result of use or reliance upon posted
or archived material.
************************************************************
Become a ProMED-mail Premium Subscriber at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send all items for posting to: promed@promedmail.org
(NOT to an individual moderator). If you do not give your
full name and affiliation, it may not be posted. Send
commands to subscribe/unsubscribe, get archives, help,
etc. to: majordomo@promedmail.org. For assistance from a
human being send mail to: owner-promed@promedmail.org.
############################################################
############################################################